Intravenous treatment with human recombinant ApoA-I Milano reduces beta amyloid cerebral deposition in the APP23-transgenic mouse model of Alzheimer's disease - Fernández de Retana Alda, Sofía; Fatar, Marc; Grudzenski-Theis, Saskia (Neurobiology of aging, 2017)
Gesehen am 16.05.2018